63 related articles for article (PubMed ID: 21252248)
1. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
Mannerås-Holm L; Baghaei F; Holm G; Janson PO; Ohlsson C; Lönn M; Stener-Victorin E
J Clin Endocrinol Metab; 2011 Apr; 96(4):1068-76. PubMed ID: 21252248
[TBL] [Abstract][Full Text] [Related]
2. Development of a Hypercoagulable-Hypofibrinolytic State Early After Spinal Cord Injury.
Park AJ; Garcia VP; Greiner JJ; Berry AR; Cardenas HL; Wegerson KN; Stauffer B; DeSouza CA
Arch Phys Med Rehabil; 2024 May; 105(5):843-849. PubMed ID: 37977547
[TBL] [Abstract][Full Text] [Related]
3. The Role of Coagulation in Heart Failure: A Literature Review.
Anjum F; Gilani M; Latif M; Sattar A; Ashraf H; Rafaqat S
Curr Heart Fail Rep; 2024 Jun; ():. PubMed ID: 38869806
[TBL] [Abstract][Full Text] [Related]
4. Can the Total Thrombus-formation Analysis System (T‑TAS) better predict coagulation disorders than conventional laboratory measurements in patients with polycystic ovary syndrome?
Ożegowska K; Mantaj U; Rojewska P; Osiński M; Pawelczyk L; Kędzia M
Pol Arch Intern Med; 2020 Dec; 130(12):1114-1117. PubMed ID: 33016685
[No Abstract] [Full Text] [Related]
5. Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome.
Moin ASM; Sathyapalan T; Diboun I; Elrayess MA; Butler AE; Atkin SL
Sci Rep; 2021 Mar; 11(1):5320. PubMed ID: 33674695
[TBL] [Abstract][Full Text] [Related]
6. Association between polycystic ovary syndrome and venous thromboembolism: A systematic review and meta-analysis.
Gariani K; Hugon-Rodin J; Philippe J; Righini M; Blondon M
Thromb Res; 2020 Jan; 185():102-108. PubMed ID: 31790999
[TBL] [Abstract][Full Text] [Related]
7. Polycystic ovary syndrome.
Stener-Victorin E; Teede H; Norman RJ; Legro R; Goodarzi MO; Dokras A; Laven J; Hoeger K; Piltonen TT
Nat Rev Dis Primers; 2024 Apr; 10(1):27. PubMed ID: 38637590
[TBL] [Abstract][Full Text] [Related]
8. Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome.
Qian Y; Tong Y; Zeng Y; Huang J; Liu K; Xie Y; Chen J; Gao M; Liu L; Zhao J; Hong Y; Nie X
J Transl Med; 2024 Apr; 22(1):364. PubMed ID: 38632610
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled clinical study of low-molecular-weight heparin improving pregnancy outcomes in PCOS women undergoing IVF: study protocol.
Huang O; Ding H; Wu D; Zhang Q; Li W
Trials; 2024 Jan; 25(1):16. PubMed ID: 38167499
[TBL] [Abstract][Full Text] [Related]
10. Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study.
Yousuf SD; Ganie MA; Mudassar S; Shafi H; Ibrahim S; Jeelani H; Rashid G; Zargar MA; Rashid F
J Family Med Prim Care; 2022 Aug; 11(8):4743-4752. PubMed ID: 36352998
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of therapeutic efficacy and effects of integrated traditional Chinese and Western medicine on coagulation and fibrinolysis system in patients with threatened abortion and polycystic ovary syndrome.
Chen X; Tao C; Wang J; He B; Xu J
Am J Transl Res; 2022; 14(5):2768-2778. PubMed ID: 35702093
[TBL] [Abstract][Full Text] [Related]
12. Reactive Thrombocytosis Related Cerebral Venous Thrombosis: A Rare Complication of Untreated Iron Deficiency Anemia.
Maryala S; Vaddiparti A
Cureus; 2021 Oct; 13(10):e19064. PubMed ID: 34853769
[TBL] [Abstract][Full Text] [Related]
13. DIA proteomics analysis through serum profiles reveals the significant proteins as candidate biomarkers in women with PCOS.
Yu Y; Tan P; Zhuang Z; Wang Z; Zhu L; Qiu R; Xu H
BMC Med Genomics; 2021 May; 14(1):125. PubMed ID: 33964924
[TBL] [Abstract][Full Text] [Related]
14. An Update on Contraception in Polycystic Ovary Syndrome.
Oguz SH; Yildiz BO
Endocrinol Metab (Seoul); 2021 Apr; 36(2):296-311. PubMed ID: 33853290
[TBL] [Abstract][Full Text] [Related]
15. The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.
Aboeldalyl S; James C; Seyam E; Ibrahim EM; Shawki HE; Amer S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800490
[TBL] [Abstract][Full Text] [Related]
16. C-Reactive Protein, Fibrinogen, Leptin, and Adiponectin Levels in Women with Polycystic Ovary Syndrome.
Ozgokce C; Elci E; Yildizhan R
J Obstet Gynaecol India; 2020 Dec; 70(6):490-496. PubMed ID: 33417636
[TBL] [Abstract][Full Text] [Related]
17. Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.
Stener-Victorin E; Padmanabhan V; Walters KA; Campbell RE; Benrick A; Giacobini P; Dumesic DA; Abbott DH
Endocr Rev; 2020 Jul; 41(4):. PubMed ID: 32310267
[TBL] [Abstract][Full Text] [Related]
18. Coagulation Biomarkers in Women with Recurrent Miscarriage and Polycystic Ovarian Syndrome: Systematic Review and Meta-Analysis.
Cavalcante MB; Sarno M; Cavalcante CTMB; Araujo Júnior E; Barini R
Geburtshilfe Frauenheilkd; 2019 Jul; 79(7):697-704. PubMed ID: 31303657
[No Abstract] [Full Text] [Related]
19. The Effect of Exenatide on Cardiovascular Risk Markers in Women With Polycystic Ovary Syndrome.
Dawson AJ; Sathyapalan T; Vince R; Coady AM; Ajjan RA; Kilpatrick ES; Atkin SL
Front Endocrinol (Lausanne); 2019; 10():189. PubMed ID: 31001199
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
